This research is Trending!
Sham-Controlled Pilot Trial of Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure With Reduced Ejection Fraction
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceAsk about this paper
Answers are grounded in this paper and cite their sources.
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Patients who remain symptomatic despite guideline-directed medical therapy need additional treatment options. Cardiac diaphragm support is a distinct approach, and this sham-controlled pilot provides an important foundation for evaluating its potential.”
“The RECOVER-HF pivotal trial is designed to provide a definitive assessment of SDS and its potential to improve the lives of patients with heart failure. The pilot has helped us shape that evaluation, which is now underway at centers in the United States and internationally.”
PBPeter BauerPresident and CEO, VisCardia
“Publication in JACC: Heart Failure is an important milestone for VisCardia and the clinical development of cardiac diaphragm support. Our focus is on advancing a minimally invasive approach that may expand treatment options for people living with heart failure.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Fudim et al. (2026) studied this question.